循环慢性淋巴细胞白血病细胞中VLA-4整合素经BCR自主信号组成性激活:一种利用可溶性血源性配体的新型非锚定依赖机制
研究报道循环CD49d阳性慢性淋巴细胞白血病(CLL)细胞中,B细胞受体(BCR)可通过不依赖抗原的自主信号从内向外激活VLA-4整合素;活化VLA-4的循环CLL细胞表达BCR通路活化标志并结合可溶性血源性VCAM-1,伊布替尼治疗可损伤该组成性VLA-4激活。
要点
- 循环CD49d阳性CLL细胞中BCR自主信号从内向外激活VLA-4整合素。
- 活化VLA-4的循环CLL细胞表达磷酸化BTK、PLC-γ2及更高水平磷酸化ERK和AKT。
- 伊布替尼通过影响自主BCR信号损伤组成性VLA-4激活,减少可溶性VCAM-1结合。
核心结论
- 本研究描述循环CLL细胞中涉及BCR与VLA-4整合素的新型非锚定依赖机制,有助于解释CD49d阳性CLL的生物学和临床特征。
研究设计与样本
- 研究为实验室研究,对象为表达CD49d的循环慢性淋巴细胞白血病细胞。
主要发现
- 循环CD49d阳性CLL细胞中BCR通过不依赖抗原的自主信号从内向外有效激活VLA-4整合素。
- 表达活化VLA-4的循环CLL细胞表达BCR通路活化标志磷酸化BTK和磷酸化PLC-γ2,并具有更高水平的磷酸化ERK和磷酸化AKT。
- 表达活化VLA-4的循环CLL细胞结合可溶性血源性VCAM-1,导致VLA-4依赖性肌动蛋白聚合/重组增加和ERK磷酸化增加。
- 伊布替尼治疗通过影响自主BCR信号损伤组成性VLA-4激活,最终减少可溶性VCAM-1结合并降低循环CLL细胞下游ERK磷酸化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In chronic lymphocytic leukemia (CLL), survival of neoplastic cells depends on microenvironmental signals at lymphoid sites where the crosstalk between the integrin VLA-4 (CD49d/CD29), expressed in ~40% of CLL, and the B-cell receptor (BCR) occurs. Here, BCR engagement inside-out activates VLA-4, thus enhancing VLA-4-mediated adhesion of CLL cells, which in turn obtain pro-survival signals from the surrounding microenvironment. We report that the BCR is also able to effectively inside-out activate the VLA-4 integrin in circulating CD49d-expressing CLL cells through an autonomous antigen-independent BCR signaling. As a consequence, circulating CLL cells exhibiting activated VLA-4 express markers of BCR pathway activation (phospho-BTK and phospho-PLC-γ2) along with higher levels of phospho-ERK and phospho-AKT indicating parallel activation of downstream pathways. Moreover, circulating CLL cells expressing activated VLA-4 bind soluble blood-borne VCAM-1 leading to increased VLA-4-dependent actin polymerization/re-organization and ERK phosphorylation. Finally, evidence is provided that ibrutinib treatment, by affecting autonomous BCR signaling, impairs the constitutive VLA-4 activation eventually decreasing soluble VCAM-1 binding and reducing downstream ERK phosphorylation by circulating CLL cells. This study describes a novel anchor-independent mechanism occurring in circulating CLL cells involving the BCR and the VLA-4 integrin, which help to unravel the peculiar biological and clinical features of CD49d+ CLL.
引用
- Tissino E, Gaglio A, Nicolò A, et al. The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands. Leukemia. 2024. PMID: 39143370. doi:10.1038/s41375-024-02376-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。